Lymphoma total lesion glycolysis leads to hyperlactatemia and reduction of brain glucose utilization.

Clarifying the mechanism of lymphoma-associated hyperlactatemia could help identify patients at risk. Here, 129 non-Hodgkin's lymphoma patients suspected of blood lactate elevation underwent blood measurement and F-fluoro-2-deoxyglucose (FDG) positron emission tomography (PET) on the same day. Blood lactate elevation was mild (1.

The role of F-fluorodeoxyglucose-positron emission tomography/computed tomography in the differential diagnosis of pericardial disease.

This study aimed to assess the role of F-fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in the differential diagnosis of pericardial disease. The diagnosis is often troublesome because pericardial fluid analysis or biopsy does not always provide answers. FDG-PET/CT can visualize both inflammation and malignancy and offers a whole-body assessment.

Inverse Prognostic Relationships of F-FDG PET/CT Metabolic Parameters in Patients with Distal Bile Duct Cancer Undergoing Curative Surgery.

Purpose: As there were few previous studies with a small number of subjects, the purpose of this was to evaluate the prognostic significance of F-FDG PET/CT in patients with distal bile duct cancer undergoing curative surgery.

Methods: The study included 40 patients (M/F = 24:16; age 68.0 ± 8.

Total FDG lesion number on PET/CT predicts survival of esophageal carcinoma patients with recurrence following curative surgery.

Background: Total lesion number is a prognostic determinant in recurrent esophageal cancer, but this requires multiple tests. Here, we investigated the prognostic value of total FDG lesion number obtained from a single PET/CT study.

Methods: Subjects were 153 esophageal squamous cell carcinoma patients with loco-regional or distant recurrence following curative surgery.

Intra-patient Variability of FDG Standardized Uptake Values in Mediastinal Blood Pool, Liver, and Myocardium during R-CHOP Chemotherapy in Patients with Diffuse Large B-cell Lymphoma.

Purpose: F-fluorodeoxyglucose (FDG) PET/CT is useful for staging and evaluating treatment response in patients with diffuse large B-cell lymphoma (DLBCL). A five-point scale model using the mediastinal blood pool (MBP) and liver as references is a recommended method for interpreting treatment response. We evaluated the variability in standardized uptake values (SUVs) of the MBP, liver, and myocardium during chemotherapy in patients with DLBCL.